Steven Bhatt

Steven Bhatt develops plasma proteomics approaches for cancer liquid biopsy, focusing on the circulating protein cargo released by tumors into the bloodstream. His research has applied highly sensitive proximity extension assay (PEA) and mass spectrometry-based proteomics to identify cancer-associated protein biomarkers in plasma. He characterized protein signatures distinguishing cancer from benign conditions across multiple cancer types in the Cancerseek and related multi-cancer detection studies. His work is advancing protein liquid biopsy panels toward clinical implementation for early cancer detection.